![Konstantinos Charizanis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Konstantinos Charizanis
Directeur/Membre du Conseil chez
U1 Bio, Inc.
Profil
Konstantinos Charizanis is currently a Director at U1 Bio, Inc. He was previously a Senior Director-Market Strategy, R&D at Ocuphire Pharma, Inc. He holds a doctorate from the University of Florida and an MBA from the Stephen M.
Ross School of Business.
Postes actifs de Konstantinos Charizanis
| Sociétés | Poste | Début |
|---|---|---|
U1 Bio, Inc.
 U1 Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA therapeutics | Directeur/Membre du Conseil | - |
Anciens postes connus de Konstantinos Charizanis
| Sociétés | Poste | Fin |
|---|---|---|
| OPUS GENETICS, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Konstantinos Charizanis
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
2
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
University of Florida
 University of Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Stephen M. Ross School of Business
 Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Ocuphire Pharma, Inc.
 Ocuphire Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes pharmaceuticals for eye disorders | Health Technology |
U1 Bio, Inc.
U1 Bio, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA therapeutics | Health Technology |
